Published in Addiction on September 01, 2009
A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research. Can J Psychiatry (2013) 1.37
The genetics of addiction-a translational perspective. Transl Psychiatry (2012) 1.30
Genetic and environmental influences on disordered gambling in men and women. Arch Gen Psychiatry (2010) 1.16
Impulse control disorders and "behavioural addictions" in the ICD-11. World Psychiatry (2014) 1.12
Fronto-striatal dysregulation in drug addiction and pathological gambling: Consistent inconsistencies? Neuroimage Clin (2013) 1.07
Gambling disorder and other behavioral addictions: recognition and treatment. Harv Rev Psychiatry (2015) 1.03
Genome-wide association study of a quantitative disordered gambling trait. Addict Biol (2012) 0.88
Multidimensional examination of impulsivity in relation to disordered gambling. Exp Clin Psychopharmacol (2014) 0.86
A direct, controlled, blind family study of DSM-IV pathological gambling. J Clin Psychiatry (2014) 0.86
Genetic basis of delay discounting in frequent gamblers: examination of a priori candidates and exploration of a panel of dopamine-related loci. Brain Behav (2014) 0.85
Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers. Front Behav Neurosci (2013) 0.84
Reduced cortical thickness in gambling disorder: a morphometric MRI study. Eur Arch Psychiatry Clin Neurosci (2015) 0.83
COMT Associations with Disordered Gambling and Drinking Measures. J Gambl Stud (2015) 0.80
Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models. Mol Psychiatry (2014) 0.79
Recreational gamblers with and without parental addiction. Psychiatry Res (2012) 0.77
Convergent functional genomics in addiction research - a translational approach to study candidate genes and gene networks. In Silico Pharmacol (2013) 0.76
Gambling disorders, gambling type preferences, and psychiatric comorbidity among the Thai general population: Results of the 2013 National Mental Health Survey. J Behav Addict (2016) 0.75
A review of gambling disorder and substance use disorders. Subst Abuse Rehabil (2016) 0.75
Neurological soft signs in individuals with pathological gambling. PLoS One (2013) 0.75
Genetic and environmental origins of gambling behaviors from ages 18 to 25: A longitudinal twin family study. Psychol Addict Behav (2017) 0.75
A Longitudinal Empirical Investigation of the Pathways Model of Problem Gambling. J Gambl Stud (2017) 0.75
Gambling Disorder: Exploring Pre-treatment and In-treatment Dropout Predictors. A UK Study. J Gambl Stud (2017) 0.75
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull (2003) 2.76
Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 2.23
Evidence that 'food addiction' is a valid phenotype of obesity. Appetite (2011) 2.02
The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet (2002) 1.98
Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment? Pharmacogenomics (2013) 1.97
Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study. Neurobiol Aging (2010) 1.77
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry (2002) 1.66
Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating. Obesity (Silver Spring) (2009) 1.65
Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res (2006) 1.64
Pharmacogenetics of psychotropic drug response. Am J Psychiatry (2004) 1.61
Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord (2003) 1.59
Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berl) (2008) 1.46
Diffusion tensor tractography findings in schizophrenia across the adult lifespan. Brain (2010) 1.43
Connexin 50 gene on human chromosome 1q21 is associated with schizophrenia in matched case control and family-based studies. J Med Genet (2007) 1.42
Pharmacogenetics in psychiatry satellite meeting at the American College of Neuropsychopharmacology, 2000. Neuropsychopharmacology (2002) 1.39
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) (2004) 1.39
Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.31
Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res (2003) 1.27
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology (2002) 1.23
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry (2012) 1.20
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels. Schizophr Res (2006) 1.18
Decision-making deficits and overeating: a risk model for obesity. Obes Res (2004) 1.16
Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia. Neuropsychobiology (2004) 1.10
Serotonin transporter polymorphisms and persistent, pervasive childhood aggression. Am J Psychiatry (2006) 1.08
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry (2004) 1.07
Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2005) 1.06
The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses. Neuropsychopharmacology (2011) 1.06
Genetics of antipsychotic treatment emergent weight gain in schizophrenia. Pharmacogenomics (2006) 1.05
The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Arch Gen Psychiatry (2011) 1.05
Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms. Am J Med Genet B Neuropsychiatr Genet (2006) 1.04
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. Pharmacogenomics (2010) 1.04
Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography. Neuroimage (2008) 1.04
Personality and eating behaviors: a case-control study of binge eating disorder. Int J Eat Disord (2008) 1.03
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res (2009) 1.03
Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder. J Psychiatr Res (2006) 1.03
Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol (2007) 1.02
Pharmacogenetics of antipsychotics. Can J Psychiatry (2014) 1.02
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett (2005) 1.02
Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. World J Biol Psychiatry (2009) 1.02
Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology (2006) 1.01
Association of attention-deficit/hyperactivity disorder with a candidate region for reading disabilities on chromosome 6p. Biol Psychiatry (2009) 1.01
'Food addiction' and its association with a dopaminergic multilocus genetic profile. Physiol Behav (2013) 0.99
A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis. Neuropsychopharmacology (2006) 0.99
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology (2010) 0.99
Pharmacogenomics in schizophrenia: the quest for individualized therapy. Hum Mol Genet (2002) 0.98
A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord (2008) 0.97
Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. Int J Neuropsychopharmacol (2005) 0.97
Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. Arch Gen Psychiatry (2007) 0.97
Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacology (2004) 0.97
Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations. Psychopharmacology (Berl) (2005) 0.97
Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud (2007) 0.97
Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia. Cereb Cortex (2012) 0.96
Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder. Bipolar Disord (2008) 0.96
Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. PLoS One (2011) 0.96
Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry (2006) 0.96
Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia. Exp Brain Res (2006) 0.96
Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 0.95
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet (2014) 0.95
Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology (2007) 0.94
Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.94
Monoamine oxidase a gene is associated with borderline personality disorder. Psychiatr Genet (2007) 0.94
Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. Am J Med Genet B Neuropsychiatr Genet (2014) 0.94
Association of the serotonin transporter and 5HT1Dbeta receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet (2004) 0.94
Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet (2010) 0.93
Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophr Res (2009) 0.92
Prenatal depression and 5-HTTLPR interact to predict dysregulation from 3 to 36 months--a differential susceptibility model. J Child Psychol Psychiatry (2014) 0.92
The dopamine D4 receptor gene and moderation of the association between externalizing behavior and IQ. Arch Gen Psychiatry (2006) 0.92
Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.91
Imaging phenotypes and genotypes in schizophrenia. Neuroinformatics (2006) 0.91
The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet (2002) 0.91
Pharmacogenetics in drug development. Philos Trans R Soc Lond B Biol Sci (2005) 0.91
Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia. Eur Neuropsychopharmacol (2005) 0.91
Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality. Psychiatry Res (2005) 0.90
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. Schizophr Res (2005) 0.90
Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology (Berl) (2005) 0.90
Genetics of antipsychotic-induced side effects and agranulocytosis. Curr Psychiatry Rep (2011) 0.90
Human p53 tumor suppressor gene (TP53) and schizophrenia: case-control and family studies. Neurosci Lett (2005) 0.90
Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol (2010) 0.89
Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet (2005) 0.89
Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders. Am J Psychiatry (2008) 0.89
Multivariate analyses suggest genetic impacts on neurocircuitry in schizophrenia. Neuroreport (2008) 0.89
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients. Int J Neuropsychopharmacol (2006) 0.88
The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults. Int J Neuropsychopharmacol (2011) 0.88
Overview of genetics and obsessive-compulsive disorder. Psychiatry Res (2009) 0.88
Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur Psychiatry (2007) 0.88
ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype. World J Biol Psychiatry (2011) 0.88
Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging Behav (2009) 0.88
Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. J Psychiatry Neurosci (2007) 0.88
No association between the Pro197Leu polymorphism in the glutathione peroxidase (GPX1) gene and schizophrenia. Psychiatr Genet (2004) 0.87
The genetics of gambling and behavioral addictions. CNS Spectr (2006) 0.87
Admixture analysis of age at onset in bipolar disorder. Psychiatry Res (2010) 0.87
NOTCH4 gene haplotype is associated with schizophrenia in African Americans. Biol Psychiatry (2004) 0.87
Mixture regression analysis on age at onset in bipolar disorder patients: investigation of the role of serotonergic genes. Eur Neuropsychopharmacol (2010) 0.87